Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Childhood Trauma Linked With Higher Odds for Adult Neurological IllsParents of Hospitalized Kids Need More Info on Costs: StudyWhich Kids Are at Highest Risk From COVID?Watch Their Backs -- Don't Overload Those SchoolbagsNeighborhood Gun Violence Means Worse Mental Health for KidsLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysChild Obesity Rose Sharply During PandemicCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciChild Cancers Are Rare, But Here Are Signs to Look ForGetting Kids Eyeglasses Boosts School Grades: StudyEczema Can Take Toll on Child's Mental HealthCOVID Cases Rise Sharply Among Kids as School Year StartsKids Piled on Extra Pounds During PandemicYour Young Child Is Sick: Is it COVID or RSV?As Classes Resume, Some Health Tips From the CDCFDA Warns Against 'Off-Label' Use of Pfizer Vaccine in Younger ChildrenParents' Poll Finds Strong Support for Vaccination of Students, TeachersTeachers' Unions, Doctors Agree: Vaccines, Masks Crucial for Return-to-School4 Out of 10 Parents Have No Plans to Get Child Vaccinated for School: PollCommon Pesticide to Be Banned Over Links to  Problems in ChildrenDiabetes in Pregnancy Tied to Eye Issues in KidsChild Injuries, Deaths Spur Recall of 10 Million Magnet Balls, CubesBabies, Toddlers Spread COVID Faster in the Home Than Teens Do: StudyGet Your Kids on a School-Ready Sleep ScheduleNew Clues to What Triggers Dangerous Syndrome in Kids With COVIDModerna COVID Vaccine Safe, Effective in Teens: StudyU.S. Kids Are Eating More 'Ultraprocessed' FoodsEasy Steps to Get Your Child Ready for the COVID-19 VaccineKeeping Classrooms Safe for Kids With Asthma, AllergiesIs the Delta Variant Hitting Kids Harder?White House Outlines Effort to Vaccinate Young as Schools Start to ReopenAHA News: Protecting Children's Mental Health as They Head Back to SchoolParents' Pot Smoking Means More Colds, Flu for KidsTroubling Rise Seen in Both COVID, RSV Cases Among ChildrenPfizer, Moderna to Expand Vaccine Studies in Young ChildrenCan COVID Transmit Easily on Crowded School Buses?Kids Still Dying From Accidental Exposure to Fentanyl Pain PatchesWhen Are Head Injury Risks Highest for Young Soccer Players?Simple Step Gets More School Kids Eating Their VeggiesSurvey Finds U.S. Parents Split on COVID Vaccination for Kids Under 12Most Parents Clueless About Overuse Dangers to Young Pitchers1.5 Million Kids Worldwide Lost Parent or Other Caregiver to COVID-19Prescriptions for U.S. Kids Declined During PandemicHow Your Kid's Education Could Make You HealthierPediatricians' Group: All School Kids, Staff Should Continue to Wear MasksAny COVID Infection Leaves Strong Antibody Levels in KidsMake Summer Camp Safe for Your Child With Asthma, AllergiesDrowning Deaths for U.S. Kids Have Fallen 38% Since 1999Heart Troubles Ease Over Time in Kids With MIS-CHalf of U.S. Teens Plan to Get COVID Shot, But Can Numbers Go Higher?
Links
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Any COVID Infection Leaves Strong Antibody Levels in Kids

HealthDay News
by Robert Preidt
Updated: Jul 19th 2021

new article illustration

MONDAY, July 19, 2021 (HealthDay News) -- Even a mild or asymptomatic case of COVID-19 triggers a strong antibody response in children and teens, new research shows.

"These findings are encouraging, especially because we cannot yet vaccinate children under the age of 12 against the virus," said study co-lead author Jillian Hurst, an assistant professor in the Department of Pediatrics at Duke University School of Medicine in Durham, N.C.

"The study shows that children who've had mild infections or even those who did not have any symptoms, develop an immune response that will likely provide some protection against future infections," Hurst said in a university news release.

She and her colleagues measured antibody response in 69 young patients, aged 2 months to 21 years, with asymptomatic and mild symptomatic SARS-CoV-2 infection. The median age was 11.5 years, and 51% were female.

Antibody response in the children did not differ based on the presence of symptoms, and antibodies against the coronavirus were still present in most of participants up to four months after infection.

The researchers also found that regardless of age, the children's antibody levels were the same or slightly higher than adults at two and four months after infection, according to the study published recently in the journal JCI Insight.

The findings suggest that giving COVID-19 vaccines to young children could lead to a level of antibody protection that's similar to or greater than that of adults, the researchers noted.

"Most studies of the immune responses of children to SARS-CoV-2 have focused on patients hospitalized for severe COVID-19 or multi-system inflammatory syndrome in children [MIS-C], or have assessed immunity only during acute infection," said study senior author Dr. Genevieve Fouda, an associate professor in the Departments of Pediatrics and Molecular Genetics and Microbiology at Duke.

"Our study provides important information that SARS-CoV-2-specific immune responses, regardless of disease severity, may decline over time more slowly in children and adolescents," Fouda said in the release.

More information

The American Academy of Pediatrics has more on COVID-19.

SOURCE: Duke University, news release, July 16, 2021




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net